Paper Details

  1. Home
  2. Paper Details

Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review.

Author: AbiyeAlfoalem Araba, KedirHanan Muzeyin, SisayEskinder Ayalew

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Aspirin is commonly used to prevent cardiovascular disease, but it can cause gastrointestinal (GI) toxicity, ranging from mucosal damage to death.
Paper Details　
Original Abstract of the Article :
Aspirin appeared as a medicine to deal with aches and inflammation, but due to its antiplatelet properties, it has evolved into a drug mainly used to avert cardiovascular disease. Regardless of its therapeutic uses, the limiting aspect for aspirin use has been its affiliation with gastrointestinal (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403009/

データ提供：米国国立医学図書館（NLM）

Enteric-Coated Aspirin: Balancing Cardiovascular Benefits and Gastrointestinal Risks

Aspirin, a widely used medication for pain relief and cardiovascular disease prevention, is known to carry a risk of gastrointestinal (GI) side effects. This systematic review delves into the complex relationship between enteric-coated aspirin and the risk of GI complications, providing a comprehensive overview of the current understanding of this important issue. The authors meticulously analyze relevant studies to evaluate the effectiveness of enteric-coated aspirin in minimizing GI toxicity, providing valuable insights for clinicians and patients.

Enteric-Coated Aspirin: A Strategy to Mitigate GI Risks

The review indicates that enteric-coated aspirin, designed to release the drug in the small intestine, can help reduce the risk of GI side effects compared to standard aspirin formulations. However, the authors emphasize that individuals taking aspirin, regardless of formulation, should be monitored for potential GI complications.

Navigating Aspirin Therapy Safely

This review highlights the importance of weighing the cardiovascular benefits of aspirin against its potential GI risks. It underscores the need for a personalized approach, considering individual factors and potential interactions with other medications, to ensure safe and effective aspirin therapy.

Dr. Camel's Conclusion

The review reveals that enteric-coated aspirin offers a strategy to mitigate GI risks associated with aspirin therapy. Think of it like a camel adapting to the desert environment by developing specialized adaptations to conserve water and survive harsh conditions.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-04-26
Further Info :

Pubmed ID

34466020

DOI: Digital Object Identifier

PMC8403009

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.